13F

Stock

Kairos Pharma, LTD.

KAPA · held by 14 managers

Reported value

$578.5K

Holders

14

+0 new · −1 exited

Holders’ est. mark

−$62

Price effect on 1 books still in the name

Largest holder

$228.4K

Citadel

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Citadel321.7K$228.4KHeld
Vanguard131.8K$93.6KHeld
TWO SIGMA INVESTMENTS, LP94K$66.7KHeld
GEODE CAPITAL MANAGEMENT, LLC72.8K$51.7KHeld
XTX Topco Ltd48.5K$34.4KHeld
SevenBridge Financial Group, LLC44.3K$31.9KHeld
Aptus Capital Advisors, LLC44.3K$31.4KHeld
State Street24.1K$17.1KHeld
TWO SIGMA ADVISERS, LP15.1K$10.8KHeld
OSAIC HOLDINGS, INC.13K$9.26KHeld
Tower Research Capital LLC (TRC)4.23K$3KHeld
BANK OF AMERICA CORP /DE/134$95−$62Cut−$261
HRT FINANCIAL LP21.3K$15Held
Virtu Financial LLC20.3K$14Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.